Related Experiment Videos
Altering T-cell activation by targeting the multidomain tyrosine kinase Itk
Steven B Kanner1, Juan J Perez-Villar
1Immunology and Oncology Drug Discovery, Bristol-Myers Squibb Pharmaceutical Research Institute, P.O. Box 4000, Princeton, NJ 08543, USA.
Trends in Immunology
|May 10, 2003
Abstract
No abstract available in PubMed .